Leonid Gibiansky

7PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsDynamical systems in applicationsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2025
Tocilizumab Dosing for Management of T Cell-Engaging Bispecific Antibody-Related CRS in Patients With R/R B-Cell NHL.

Candice Jamois, David C Turner, Leonid Gibiansky

|Feb 12, 2025
Optimal Dosing Regimen for Epcoritamab, a Subcutaneous Bispecific Antibody, in Relapsed or Refractory Large B-Cell Lymphoma.

Tommy Li, Leonid Gibiansky, Apurvasena Parikh

|Apr 16, 2024
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study.

Rong Deng, Leonid Gibiansky, Tong Lu

|Nov 23, 2023
Population PK/PD modeling of low-density lipoprotein cholesterol response in hypercholesterolemic participants following administration of bococizumab, a potent anti-PCSK9 monoclonal antibody.

Ellen Q Wang, Nitin Kaila, David Plowchalk

|Jul 27, 2023
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.

Chaitali Passey, Jenna Voellinger, Leonid Gibiansky

|Sep 18, 2017
Mathematical description of drug-target interactions: application to biologics that bind to targets with two binding sites.

Leonid Gibiansky, Ekaterina Gibiansky

Pageof 2

Frequent Collaborators

1 joint publications

Nitin Kaila

1 joint publications

Tong Lu

1 joint publications

Dale Miles

1 joint publications

Tommy Li